ResoluteAI, the Connect to Discover™ company, today announced the launch of Nebula, its enterprise search solution for scientific organizations. Nebula tags and categorizes users' content, connecting their proprietary information to ResoluteAI's platform of comprehensive scientific databases.
tellic, a technology startup based in New York, NY has been working for five years to develop an AI tool that surfaces actionable insights from biomedical research. Numerous biopharma currently use tellic graph as an AI-powered literature review tool to expedite their research.
A recently signed New Mexico law enables Sandia and Los Alamos national laboratories to assist in turning transferred technology into viable products and services, which could boost innovation and create jobs, according to Sandia business development experts.
Pulsara's COVID-19 package enables networked communication (including HIPAA-compliant live video and messaging) across organizations at no charge.
Surgisphere Corporation announces the availability of a rapid diagnostic tool for novel coronavirus.
Amid escalating concerns about derivative health implications of COVID-19 and influenza illnesses in general—with dehydration paramount among the more ubiquitous health concerns as detailed in a multitude of reports—board-certified internist Dr. Blanca Lizaola-Mayo is driving awareness for, and underscoring the importance of, proper hydration—and understanding the perils of dehydration—as a way to stay healthy and better recover from sickness.
Technology for a smart mouthguard from the University of Maryland, Baltimore (UMB) has been licensed by University of Maryland School of Dentistry (UMSOD) alumnus Michael Wright, DDS, MS, into his new startup company, The WrightGuard Innovation Corporation.
Ceevra, Inc., a San Francisco-based advanced visualization platform for surgeons, today announced that renowned urologic oncology surgeon, Dr. James Porter, has commercially adopted Ceevra’s mobile 3D visualization platform to help plan and perform his kidney cancer operations.
Healthcare professionals of all experience levels attend the IMSH conference to advance their skills, to impact change in their organizations, and, ultimately, to improve patient safety.
La Jolla Institute for Immunology (LJI) is placing their confidence in Berkeley Lights’ Beacon® Optofluidic Platform and B cell antibody discovery workflow to accelerate the discovery of rare and lifesaving antibodies for the treatment of re-emerging and emerging diseases.
Showing results
1–10 of 10
RSS Feeds by Section